| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF01309384 |
| P698 | PubMed publication ID | 2865092 |
| P2093 | author name string | Coruzzi G | |
| Bertaccini G | |||
| P2860 | cites work | Effect of verapamil on gastric secretion in man | Q70482122 |
| Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization | Q71864873 | ||
| Pirenzepine and exocrine secretions: a selective agent for gastric glands? | Q72579608 | ||
| Pirenzepine (LS 519): A weak inhibitor of acid secretion by isolated rat parietal cells | Q72689401 | ||
| Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPase | Q34252248 | ||
| Calcium Channel Antagonists Verapamil and Gallopamil Are Powerful Inhibitors of Acid Secretion in Isolated and Enriched Guinea Pig Parietal Cells | Q34254963 | ||
| Structure-Activity Relationships of Somatostatin Analogs in the Rabbit Ileum and the Rat Colon | Q35205355 | ||
| Cytoprotection by prostaglandins | Q39263861 | ||
| Comparison of the healing capacities of sucralfate and cimetidine in the short-term treatment of duodenal ulcer: a double-blind randomized trial | Q39564365 | ||
| Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate | Q39568759 | ||
| Increased healing of gastric and duodenal ulcers in a controlled trial using tripotassium dicitrato-bismuthate | Q40791881 | ||
| Differentiation among inhibitory actions of omeprazole, cimetidine, and SCN- on gastric acid secretion | Q42453125 | ||
| Effect of verapamil on basal and pentagastrin-stimulated gastric acid secretion | Q42465545 | ||
| The inhibitory effects of 5-hydroxytryptamine on gastric acid secretion by the rat isolated stomach | Q42635327 | ||
| Definition and antagonism of histamine H 2 -receptors | Q46704110 | ||
| Calcium and stimulus-secretion coupling in gastric fundic mucosa. Effect of inhibition of calcium transport by verapamil on gastric acid secretion in the isolated guinea pig fundic mucosa and in healthy subjects. | Q53935502 | ||
| Assessment of "Ca2+ -antagonist" effects of drugs in K+ -depolarized smooth muscle. Differentiation of antagonist subgroups. | Q53938418 | ||
| A bismuth-peptide complex in the treatment of duodenal ulceration. A double-blind duodenoscopic study | Q66898533 | ||
| Protective Action of Omeprazole, a Benzimidazole Derivative, on Gastric Mucosal Damage by Aspirin and Ethanol in Rats | Q70290503 | ||
| Dose-response study of omeprazole on meal-stimulated gastric acid secretion and gastrin release | Q70290554 | ||
| P433 | issue | 11 Suppl | |
| P921 | main subject | pharmacology | Q128406 |
| P304 | page(s) | 43S-51S | |
| P577 | publication date | 1985-11-01 | |
| P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
| P1476 | title | Pharmacology of the treatment of peptic ulcer disease | |
| P478 | volume | 30 |
| Q36915489 | 11β-hydroxysteroid dehydrogenase inhibition as a new potential therapeutic target for alcohol abuse |
| Q90575658 | A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma |
| Q70376963 | Evaluation of antisecretory activity of misoprostol in duodenal ulcer patients using long-term intragastric pH monitoring |
| Q90175576 | Probenecid Reduces Alcohol Drinking in Rodents. Is Pannexin1 a Novel Therapeutic Target for Alcohol Use Disorder? |
| Q35993749 | Sulforaphane Inhibits HIV Infection of Macrophages through Nrf2. |
Search more.